Nuclear Medicine News and Research RSS Feed - Nuclear Medicine News and Research

Nuclear medicine is a branch or specialty of medicine and medical imaging that uses radioactive isotopes (radionuclides) and relies on the process of radioactive decay in the diagnosis and treatment of disease. In nuclear medicine procedures, radionuclides are combined with other chemical compounds or pharmaceuticals to form radiopharmaceuticals.
Loyola offers patients the most advanced PET/CT scanner

Loyola offers patients the most advanced PET/CT scanner

Loyola University Medical Center is now offering patients the most advanced PET/CT scanner on the market. The state-of-the-art system is improving the diagnosis and treatment of cancer, heart disease, epilepsy, Alzheimer's disease and other conditions. [More]
Neuroinflammation levels higher in patients with chronic fatigue syndrome

Neuroinflammation levels higher in patients with chronic fatigue syndrome

Researchers at the RIKEN Center for Life Science Technologies, in collaboration with Osaka City University and Kansai University of Welfare Sciences, have used functional PET imaging to show that levels of neuroinflammation, or inflammation of the nervous system, are higher in patients with chronic fatigue syndrome than in healthy people. [More]

Fourth Herbert A. Fleisch ESCEO-IOF Medal awarded to Belgian researcher at Ghent University Hospital

​The 4th Herbert A. Fleisch ESCEO-IOF Medal was awarded today to eminent Belgian researcher Jean-Marc Kaufman, Professor of Medicine at the Ghent University Hospital, Ghent, Belgium. [More]

Toshiba launches sleek, lightweight ultrasound system, Xario 200

Hospitals and imaging centers of any size can now access premium image quality with Toshiba America Medical Systems, Inc.'s Xario™ 200. The all-new ultrasound system is sleek and lightweight and takes the worry out of providing high-quality patient care with a compact ultrasound system. [More]

Toshiba launches CardioLine software for faster and more accurate MR cardiac exams

MR cardiac exams are faster and more accurate with new tools from Toshiba America Medical Systems, Inc. CardioLine, now available on the Vantage Titan™ 1.5T and 3T MR systems, improves workflow and standardizes exams to meet the pressures of today's cardiology market. [More]

Pacific Vascular purchases Toshiba's Aplio 300 ultrasound systems

Pacific Vascular, Inc. is providing its patients with the latest in ultrasound technology by acquiring 36 Aplio 300 ultrasound systems from Toshiba America Medical Systems, Inc. [More]
PET eliminates approximately 50% of unnecessary surgeries in lung cancer patients

PET eliminates approximately 50% of unnecessary surgeries in lung cancer patients

New quantitative data suggests that 30 percent of the surgeries performed for non-small cell lung cancer patients in a community-wide clinical study were deemed unnecessary. [More]

Study lays groundwork for PET imaging studies on human Menkes disease

Scientists at the RIKEN Center for Life Science Technologies have used PET imaging to visualize the distribution in the body of copper, which is deregulated in Menkes disease, a genetic disorder, using a mouse model. This study lays the groundwork for PET imaging studies on human Menkes disease patients to identify new therapy options. [More]

FDA clears Toshiba’s CT Myocardial Perfusion technology

To improve cardiac diagnoses with simplified dose reduction technology, Toshiba announces the FDA clearance of its industry-exclusive CT Myocardial Perfusion capability. Available on Toshiba's AquilionTM ONE and Aquilion ONE ViSION Edition CT systems. [More]
3D mammography now available at Lenox Hill Radiology

3D mammography now available at Lenox Hill Radiology

Lenox Hill Radiology, a wholly owned subsidiary of RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announces that 3D mammography, the latest innovation in breast cancer screening, is now available at its 79th Street location on the Upper West Side. [More]
Researchers determine affected areas of brain using speech processing tests with aid of fMRT

Researchers determine affected areas of brain using speech processing tests with aid of fMRT

The brain processes read and heard language differently. This is the key and new finding of a study at the University Department of Radiology and Nuclear Medicine at the MedUni Vienna, unveiled on the eve of the European Radiology Congress in Vienna (6 to 10 March). [More]
7-Tesla ultra-high-field MRI facilitates more accurate diagnosis of breast cancer, says study

7-Tesla ultra-high-field MRI facilitates more accurate diagnosis of breast cancer, says study

Taking part in a recent study, scientists at the MedUni Vienna have demonstrated for the first time worldwide that 7-Tesla ultra-high-field magnetic resonance imaging (MRI) can be used for clinical applications in patients with breast tumours. [More]
AAA gets orphan drug designation status for radiopharmaceutical, Gallium-68 DOTATATE

AAA gets orphan drug designation status for radiopharmaceutical, Gallium-68 DOTATATE

Advanced Accelerator Applications (AAA), a fast growing international player in Molecular Nuclear Medicine (MNM), announced today that they have received orphan drug designation status for their radiopharmaceutical, Gallium-68 DOTATATE. [More]

Advanced Accelerator Applications agrees to acquire 100% shares of Imaging Equipment

Advanced Accelerator Applications, a fast growing international specialist in Molecular Nuclear Medicine (MNM), announced today that it has entered into an agreement to acquire 100% of the shares of Imaging Equipment Ltd, a privately-held UK distributor of nuclear medicine products and technologies, in newly issued AAA shares. [More]
UCLA develops experimental treatment that eliminates acute type of leukemia in mice

UCLA develops experimental treatment that eliminates acute type of leukemia in mice

A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center has developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. [More]
UCLA scientists developed experimental treatment that eradicates acute type of leukemia in mice

UCLA scientists developed experimental treatment that eradicates acute type of leukemia in mice

A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center have developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread. [More]

Advanced Accelerator Applications successfully completes capital increase of €41 million

Advanced Accelerator Applications, a fast growing international specialist in Molecular Nuclear Medicine (MNM), announced today that it had successfully completed a capital increase of €41 million. [More]
Toshiba, AHRA announce recipients of 2013 Putting Patients First grant program

Toshiba, AHRA announce recipients of 2013 Putting Patients First grant program

Helping facilities develop or improve existing education and patient care initiatives in diagnostic imaging, AHRA: The Association for Medical Imaging Management and Toshiba America Medical Systems, Inc. announced the seven recipients of the sixth annual Putting Patients First grant program. Recipients were judged on their program plan and ability to share best practices for improving patient care and safety in CT, MR, Ultrasound, X-ray and Vascular imaging. [More]
Chinese and American researchers introduce new approach to gene therapy

Chinese and American researchers introduce new approach to gene therapy

Resistance of tumor cells toward multiple cytostatic drugs is a serious problem in cancer treatment. In the journal Angewandte Chemie, a team of Chinese and American researchers has now introduced a new approach to gene therapy that could counter this problem: The gene that codes for resistance is “silenced” through the use of an ingenious nanocomplex. [More]

HealthTrust selects BC Technical as provider for refurbished medical imaging equipment

BC Technical, a leading non-OEM medical imaging solutions provider, announced today that it has been selected by HealthTrust as a provider for refurbished medical imaging equipment for the 1,400 acute care facilities that are part of the HealthTrust membership. [More]